Search
| Leader | 00000nz a2200037n 45 0 | ||
|---|---|---|---|
| 001 | WKP|Q88450650 (VIAF cluster) (Authority/Source Record) | ||
| 003 | WKP | ||
| 005 | 20241120235956.0 | ||
| 008 | 241120nneanz||abbn n and d | ||
| 035 | ‡a (WKP)Q88450650 | ||
| 024 | ‡a 0000-0003-1581-6486 ‡2 orcid | ||
| 035 | ‡a (OCoLC)Q88450650 | ||
| 100 | 0 | ‡a Glen B Baker ‡c researcher ‡9 en | |
| 400 | 0 | ‡a Glen B Baker ‡c wetenschapper ‡9 nl | |
| 670 | ‡a Author's Body fluid levels of neuroactive amino acids in autism spectrum disorders: a review of the literature. | ||
| 670 | ‡a Author's Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers | ||
| 670 | ‡a Author's Neuroimmunological antibody-mediated encephalitis and implications for diagnosis and therapy in neuropsychiatry | ||
| 670 | ‡a Author's Regulation of Diabetes: a Therapeutic Strategy for Alzheimer's Disease? | ||
| 909 | ‡a (orcid) 0000000315816486 ‡9 1 | ||
| 919 | ‡a ketamineasanantidepressantoverviewofitsmechanismsofactionandpotentialpredictivebiomarkers ‡A Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers ‡9 1 | ||
| 919 | ‡a neuroimmunologicalantibodymediatedencephalitisandimplicationsfordiagnosisandtherapyinneuropsychiatry ‡A Neuroimmunological antibody-mediated encephalitis and implications for diagnosis and therapy in neuropsychiatry ‡9 1 | ||
| 919 | ‡a regulationofdiabetesatherapeuticstrategyforalzheimersdisease ‡A Regulation of Diabetes: a Therapeutic Strategy for Alzheimer's Disease? ‡9 1 | ||
| 919 | ‡a bodyfluidlevelsofneuroactiveaminoacidsinautismspectrumdisordersareviewoftheliterature ‡A Body fluid levels of neuroactive amino acids in autism spectrum disorders: a review of the literature. ‡9 1 | ||
| 996 | ‡2 LC|no 94028117 | ||
| 996 | ‡2 LC|n 2005085590 | ||
| 996 | ‡2 ISNI|0000000050143529 | ||
| 996 | ‡2 LC|nr 95005705 | ||
| 996 | ‡2 NUKAT|n 97007006 | ||
| 996 | ‡2 LC|n 86045097 | ||
| 996 | ‡2 CAOONL|ncf10207806 | ||
| 996 | ‡2 CAOONL|ncf10605931 | ||
| 996 | ‡2 CAOONL|ncf10166215 | ||
| 996 | ‡2 ISNI|0000000116956320 | ||
| 996 | ‡2 LC|nb2005008318 | ||
| 996 | ‡2 NTA|314841474 | ||
| 996 | ‡2 J9U|987007457650305171 | ||
| 996 | ‡2 NTA|069024502 | ||
| 996 | ‡2 ISNI|0000000035726566 | ||
| 996 | ‡2 BIBSYS|90815120 | ||
| 996 | ‡2 LC|n 86124425 | ||
| 996 | ‡2 ISNI|0000000138743772 | ||
| 996 | ‡2 BIBSYS|63888 | ||
| 996 | ‡2 CAOONL|ncf10510875 | ||
| 996 | ‡2 NTA|072481382 | ||
| 996 | ‡2 BNE|XX862794 | ||
| 996 | ‡2 LC|n 87889105 | ||
| 996 | ‡2 J9U|987012329647805171 | ||
| 996 | ‡2 J9U|987007384678905171 | ||
| 996 | ‡2 SUDOC|189009241 | ||
| 996 | ‡2 ISNI|0000000030861216 | ||
| 996 | ‡2 NII|DA07734658 | ||
| 996 | ‡2 NUKAT|n 2008137030 | ||
| 996 | ‡2 DBC|87097969373968 | ||
| 996 | ‡2 ISNI|0000000384859420 | ||
| 996 | ‡2 LC|no2009122237 | ||
| 996 | ‡2 LC|n 82085435 | ||
| 996 | ‡2 LC|n 88626769 | ||
| 996 | ‡2 LC|n 2006169817 | ||
| 996 | ‡2 NUKAT|n 2021006573 | ||
| 996 | ‡2 ISNI|0000000041207738 | ||
| 996 | ‡2 J9U|987007363635805171 | ||
| 996 | ‡2 ISNI|0000000024987971 | ||
| 996 | ‡2 NDL|00552031 | ||
| 996 | ‡2 NII|DA18107558 | ||
| 996 | ‡2 ISNI|0000000073587085 | ||
| 996 | ‡2 ISNI|0000000116921160 | ||
| 996 | ‡2 BNF|12326942 | ||
| 996 | ‡2 CAOONL|ncf10098045 | ||
| 996 | ‡2 LC|n 80046278 | ||
| 996 | ‡2 LC|no2022154411 | ||
| 996 | ‡2 BIBSYS|90251504 | ||
| 996 | ‡2 RERO|A023745590 | ||
| 996 | ‡2 BIBSYS|99027182 | ||
| 996 | ‡2 LC|n 87933430 | ||
| 996 | ‡2 LC|n 84209247 | ||
| 996 | ‡2 ISNI|0000000029051275 | ||
| 996 | ‡2 SUDOC|032190921 | ||
| 997 | ‡a 0 0 lived 0 0 ‡9 1 |
